Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

How statins may increase prostate cancer.

Goldstein MR, Mascitelli L, Pezzetta F.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):459. doi: 10.1158/1055-9965.EPI-07-2776. No abstract available.

2.

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ.

J Natl Cancer Inst. 2008 Feb 6;100(3):170-83. doi: 10.1093/jnci/djm323. Epub 2008 Jan 29.

PMID:
18230794
3.

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32.

4.

Statin use and risk of prostate cancer in the California Men's Health Study cohort.

Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP Jr, Sternfeld B, Jacobsen SJ, Whitmer RA, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2218-25. Epub 2007 Oct 30.

5.

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.

Jacobs EJ, Rodriguez C, Bain EB, Wang Y, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2213-7. Epub 2007 Oct 30.

6.

Do statins affect androgen levels in men? Results from the Boston area community health survey.

Hall SA, Page ST, Travison TG, Montgomery RB, Link CL, McKinlay JB.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1587-94.

7.

Statin use and the risk of 10 cancers.

Coogan PF, Rosenberg L, Strom BL.

Epidemiology. 2007 Mar;18(2):213-9.

PMID:
17235211
8.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

PMID:
17179483
9.

Statins and risk of cancer: a systematic review and metaanalysis.

Browning DR, Martin RM.

Int J Cancer. 2007 Feb 15;120(4):833-43. Review.

10.

Statins and the risk of cancer.

Salinas CA, Agalliu I, Stanford JL, Lin DW.

JAMA. 2006 Jun 21;295(23):2721; author reply 2721-2. No abstract available.

PMID:
16788124
11.

Statins and the risk of cancer.

Freeman MR, Solomon KR, Moyad M.

JAMA. 2006 Jun 21;295(23):2720-1; author reply 2721-2. No abstract available.

PMID:
16788122
12.

Statins and cancer risk: a meta-analysis.

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM.

JAMA. 2006 Jan 4;295(1):74-80.

PMID:
16391219
13.

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084.

PMID:
16214597
14.

Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin.

Gotto AM Jr.

Am J Cardiol. 2005 Sep 5;96(5A):34F-38F. Review.

PMID:
16126021
15.

Statins and prostate cancer risk: a case-control study.

Shannon J, Tewoderos S, Garzotto M, Beer TM, Derenick R, Palma A, Farris PE.

Am J Epidemiol. 2005 Aug 15;162(4):318-25. Epub 2005 Jul 13.

PMID:
16014776
16.

Statin response and pharmacokinetics variants.

Kajinami K, Masuya H, Hoshiba Y, Takeda K, Sato R, Okabayashi M, Schaefer EJ.

Expert Opin Pharmacother. 2005 Jul;6(8):1291-7. Review.

PMID:
16013979
17.

Cancer risk among statin users: a population-based cohort study.

Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP, Dalton SO, Sørensen HT, Olsen JH.

Int J Cancer. 2005 Apr 20;114(4):643-7.

18.

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.

Graaf MR, Richel DJ, van Noorden CJ, Guchelaar HJ.

Cancer Treat Rev. 2004 Nov;30(7):609-41. Review.

PMID:
15531395
19.

Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Bellosta S, Paoletti R, Corsini A.

Circulation. 2004 Jun 15;109(23 Suppl 1):III50-7. Review.

20.

The risk of cancer in users of statins.

Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ, Guchelaar HJ.

J Clin Oncol. 2004 Jun 15;22(12):2388-94.

PMID:
15197200

Supplemental Content

Support Center